Statin drugs are widely used to manage high cholesterol and reduce the risk of cardiovascular disease. But in a new review of more than 50 studies, researchers cite reductions in liver inflammation and improvements in other related factors as reasons why statins make good candidates for treating chronic liver disease.
Physician researchers at Thomas Jefferson University suspect that some cases of coronary artery spasm go unrecognized and are incorrectly treated with stents. The good news – there could be a simple fix to eliminate these unnecessary stenting procedures. The team published a case series in Catheterization and Cardiovascular Interventions.
Researchers have developed a new way of visualizing the distribution of cholesterol in cells and tissues. Their research provides insights into the movement of cholesterol into and out of cells and could eventually identify mechanisms linking cholesterol to coronary artery disease.
Ablation procedures restore a regular heartbeat in patients who have a dangerous, abnormal heart rhythm called atrial fibrillation. But it doesn’t always work. Now, a new study suggests that certain molecules are associated with the recurrence of erratic heartbeats in some patients after ablation therapy.
Researchers are revisiting their views on the relative dangers soft and hard atherosclerotic plaque deposits pose to heart health. Findings of a new study by researchers at the Intermountain Medical Center Heart Institute may be a “game-changer” for determining who’s at risk of a heart attack, they say.
Combining two independent, scientifically-proven risk measurements allows physicians to better predict an atrial fibrillation patient’s risk of stroke or death. The tools also help determine the need for blood thinners in treatment, according to new research from researchers at the Intermountain Medical Center Heart Institute in Salt Lake City.
Study investigates whether modern statin guidelines accurately identify African American patients with atherosclerotic cardiovascular disease.
A typical intervention for PE patients includes anticoagulants in an effort to prevent migration of the blood clot, but the higher-risk PE population – about 30 percent of all PE patients – are potential candidates for catheter-directed thrombolysis (CDT) and systemic thrombolysis (ST), both of which employ “clot-busting” medications known as tissue plasminogen activator (tPA). However, in a new study presented today at the American College of Cardiology 66th Annual Scientific Session, researchers from the Perelman School of Medicine at the University of Pennsylvania have found that the utilization rates of these potentially life-saving medications are low, particularly in the sub-group of PE patients who are critically ill.
Patients with hypertrophic cardiomyopathy are urged to take it easy. But new research shows they might benefit from moderate aerobic exercise.
Findings from a large, community-based study show that antithrombotic therapy doesn’t decrease low-risk atrial fibrillation patients’ risk of suffering a stroke within five years. In fact, researchers found that low-risk patients fared better without any antithrombotic therapy.
For patients with persistent AF or those who are at high risk for recurring AF, catheter ablation – a minimally invasive procedure in which the areas of the heart causing the irregularity are cauterized – is recommended, followed most often by continued use of blood thinners, regardless of whether the ablation procedure was effective. In new study presented today at the American College of Cardiology Annual Scientific Sessions, researchers from the Perelman School of Medicine at the University of Pennsylvania have found that patients with persistent AF, who are successfully treated with ablation many, in fact, no longer need blood thinners.
Medtronic plc (NYSE: MDT) today unveiled first-ever clinical data from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Trial, which was presented at the American College of Cardiology (ACC) 66th Annual Scientific Session and published simultaneously in The New England Journal of Medicine (NEJM) (1).
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City finds that combining information from routine blood tests and age of primary care patients can create a score that measures future risk of chronic disease.
New research suggests that GlycA, a newly identified blood marker, and C-reactive protein both independently predict major adverse cardiac events, including heart failure and death. Patients who have high levels of both biomarkers are at especially high risk.
Faculty and fellows from the Cardiovascular Research Foundation (CRF) will be presenting abstracts at the American College of Cardiology 66th Annual Scientific Session taking place March 17-19, 2017 at the Walter E. Washington Convention Center in Washington, DC. They will be sharing the latest data on drug-eluting stents, left main coronary disease, imaging technologies, dual antiplatelet therapy and other topics.
A heart attack can happen even if to those who are relatively young and fit, and genetics can play a role.
A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.
Patients on statins should not stop taking the cholesterol-lowering medication before heart surgery—even on the day of surgery, according to an article posted in The Annals of Thoracic Surgery.
A $9.7 million National Institutes of Health project grant to Penn State College of Medicine aims to improve the lives of millions of people living with peripheral arterial disease.
Physicians, fellows, and researchers from Mount Sinai Health System will present research updates and clinical findings at the American College of Cardiology’s 66th Annual Scientific Sessions in Washington, D.C., March 17-19, 2017.
It’s a rare, but tragic, event that occurs less than 20 times a year: Teen athletes who are struck in the chest by a ball, causing their heart to stop. And it can be instantly fatal.
Coronary artery disease is caused by plaque buildup in the vessels that deliver blood to the heart. Narrowed or blocked coronary arteries can result in a heart attack or sudden cardiac death. A study at the University of Missouri School of Medicine revealed that ammonia plays an important role in maintaining cardiovascular health. Researchers say that non-toxic amounts of the gas could help prevent coronary artery disease.
Depression is the strongest predictor of death in the first decade following a diagnosis of coronary heart disease, according to a new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City.
Renowned cardiac metabolism expert Daniel P. Kelly, MD, has been named director of the Penn Cardiovascular Institute, a multi-disciplinary group of researchers and physicians dedicated to scientific discoveries and medical breakthroughs in heart and vascular care. He will lead a cross-disciplinary team of basic, translational and clinical researchers, leveraging laboratory research to develop the next generation of therapies for cardiovascular disease.
A new type of blood test may help physicians identify which patients with and without evidence of coronary blockages are at risk for heart attacks and strokes. Even individuals with normal levels of low-density lipoprotein (LDL), known as the so-called “bad” cholesterol, but still at risk, seem to be identified, according to Mayo Clinic research being presented at the American College of Cardiology’s 66th Annual Scientific Session.
Zika also may have serious effects on the heart, new research shows in the first study to report cardiovascular complications related to this virus, according to data being presented at the American College of Cardiology’s 66th Annual Scientific Session.
The gene, called CDH2, causes arrhythmogenic right ventricle cardiomyopathy (ARVC), which is a genetic disorder that predisposes patients to cardiac arrest and is a major cause of unexpected death in seemingly healthy young people.
MedStar Heart & Vascular Institute uses a new therapy option for patients at an increased risk of stroke due to atrial fibrillation, as part of a nationwide clinical trial.
The Cardiovascular Research Foundation (CRF) is pleased to announce that the submission site is now open for Structural Heart: The Journal of the Heart Team at https://mc.manuscriptcentral.com/structuralheartj. Structural Heart is a new journal that will focus on diagnosing and treating diseases of the heart valves, myocardium and great vessels, as well as congenital heart disease, and the importance of the Heart Team in this process.
The Mayo Clinic Board of Trustees approved plans for enhanced and increased procedural and patient-dedicated facilities at Mayo Clinic Hospital — Rochester, Saint Marys Campus. Mayo Clinic will invest $217 million in the growth and modernization of Saint Marys Campus, while also relocating and upgrading its Cardiac Surgery facilities.
Johns Hopkins researchers report that a new analysis of health information drawn from a national database reaffirms the missed opportunity doctors have in recommending lifestyle interventions to people with a family history of diabetes and cardiovascular disease.
Climbing above 4,000m can provoke abnormal heart rhythms in otherwise healthy mountaineers, with the abnormalities increasing with altitude, new research has shown.
Hormone replacement therapy has long been controversial as studies have associated it with health benefits and risks. While some studies suggest that it lowers the risk of osteoporosis and improves some aspects of heart health, others link it to higher risk of cancer and stroke. Now, a new imaging study by investigators at Cedars-Sinai, suggests that women using hormone replacement therapy to relieve menopause symptoms face a lower risk of death and show lower levels of atherosclerosis compared to women who do not use hormone therapy.
The new “International Criteria for ECG Interpretation in Athletes” consensus guidelines have been published by the British Journal of Sports Medicine and co-published in two prestigious cardiology journals, the Journal of the American College of Cardiology and the European Heart Journal.
Researchers at The Ohio State University Ross Heart Hospital and Nationwide Children’s Hospital have shown early treatment with eplerenone can improve heart function in young boys with Duchenne muscular dystrophy (DMD) and stabilize heart function in older boys with the disease.
As we embark on another spring of sunlit evenings, who better to address how daylight saving time affects our body clock than the father of the CLOCK gene: Dr. Joseph Takahashi of the Peter O’Donnell Jr. Brain Institute at UT Southwestern Medical Center.
A rise in caloric consumption combined with a decrease in physical activity has contributed to a boom of metabolic diseases, such as type 2 diabetes mellitus and cardiovascular diseases (e.g., heart failure and stroke).
A sweeping international effort is connecting the dots between genes in our fat cells and our risk for obesity and cardiometabolic diseases such as heart disease and type 2 diabetes. The researchers have identified approximately 90 genes found in fat that could play important roles in such diseases – and could be targeted to develop new treatments or cures.
A Whitehall, Ohio man is the first in the U.S. to undergo a new treatment designed to remove excess fluid from hospitalized patients suffering from congestive heart failure. The trial procedure occurred last week at The Ohio State University Ross Heart Hospital.
A miniaturized pacemaker that doesn’t have any wires and a coronary stent that gradually dissolves in the body – both approved by Food and Drug Administration within the past year – are being put to good use by heart and vascular specialists.
A new study shows further evidence for the view that spending too much time sitting down is bad for our health and our waistline.
Researchers have found that only 16 percent of heart attack survivors get the recommended amount of physical activity in the weeks after hospitalization, despite evidence that physical activity reduces the risk of having a second heart attack.
TSRI's Katja Lamia and her lab members are on a mission to understand how circadian proteins keep us healthy.
Heart disease is one of the most common chronic health conditions among nursing home residents. Results from the Missouri Quality Initiative for Nursing Homes (MOQI), a partnership between the University of Missouri and the Centers for Medicare & Medicaid Services, indicate that advanced practice registered nurses (APRNs) working in nursing homes to perform primary care duties are improving health outcomes for nursing home residents with heart disease.
An investigator at The Saban Research Institute of Children’s Hospital Los Angeles, has been awarded nearly $1.7 million, over a four year period, from the National Heart, Lung, and Blood Institute to study the molecular and cellular mechanisms of the heart’s circulatory system.
A Florida State University researcher will lead a joint U.S.-Russia project that will examine the effect of space travel on astronauts’ vision, an ongoing problem that NASA has been eager to solve.
5 facts about sleep apnea and its negative effects on your health.
A new study suggests that civic engagement, in the form of community-based “Change Clubs,” engages Black/African American women to address nutrition and exercise concerns in their community and motivates them to change their individual behaviors, which may improve heart health.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right